Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISERET FYSIOTERAPEUT GORM HANSEN HOLDING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   0.9% 0.6% 0.6% 1.1% 0.7% 1.9% 9.1% 9.1%   Credit score (0-100)   90 97 97 83 94 68 27 27   Credit rating   A AA AA A AA A BB BB   Credit limit (kDKK)   793.0 926.8 951.5 344.9 691.8 1.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -11.6 -11.3 -32.2 -9.2 -12.8 100 0.0 0.0   EBITDA   -11.6 -86.3 -182 -159 -163 -69.9 0.0 0.0   EBIT   -21.7 -96.5 -192 -169 -173 -69.9 0.0 0.0   Pre-tax profit (PTP)   341.3 1,789.6 1,897.1 -1,344.8 228.7 824.2 0.0 0.0   Net earnings   361.6 1,996.6 1,478.3 -1,346.3 228.3 822.4 0.0 0.0   Pre-tax profit without non-rec. items   341 1,790 1,897 -1,345 229 824 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   488 478 468 458 447 0.0 0.0 0.0   Shareholders equity total   10,069 9,566 9,844 8,498 7,612 8,316 4,883 4,883   Interest-bearing liabilities   158 52.3 31.5 87.5 131 0.0 0.0 0.0   Balance sheet total (assets)   10,493 9,672 10,367 8,658 7,886 8,416 4,883 4,883   Net Debt   -8,919 -8,288 -9,445 -7,888 -7,024 -8,327 -4,883 -4,883     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -11.6 -11.3 -32.2 -9.2 -12.8 100 0.0 0.0   Gross profit growth   -92.5% 2.0% -184.4% 71.5% -39.6% 0.0% -100.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   10,493 9,672 10,367 8,658 7,886 8,416 4,883 4,883   Balance sheet change%   1.3% -7.8% 7.2% -16.5% -8.9% 6.7% -42.0% 0.0%   Added value   -11.6 -86.3 -182.2 -159.2 -162.8 -69.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -20 -20 -20 -20 -20 -447 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   187.6% 850.8% 596.6% 1,843.0% 1,348.2% -69.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.9% 29.9% 19.1% 2.6% 5.4% 10.4% 0.0% 0.0%   ROI %   8.2% 30.4% 19.7% 2.7% 5.4% 10.6% 0.0% 0.0%   ROE %   3.6% 20.3% 15.2% -14.7% 2.8% 10.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   96.0% 98.9% 95.0% 98.2% 96.5% 98.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   77,070.3% 9,599.3% 5,182.3% 4,955.0% 4,313.8% 11,918.6% 0.0% 0.0%   Gearing %   1.6% 0.5% 0.3% 1.0% 1.7% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   358.7% 1,163.6% 46.9% 2,683.5% 198.2% 38.1% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   22.3 81.0 18.8 50.7 26.8 84.5 0.0 0.0   Current Ratio   22.3 81.0 18.8 50.7 26.8 84.5 0.0 0.0   Cash and cash equivalent   9,076.6 8,340.3 9,476.2 7,975.2 7,154.6 8,327.2 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,936.4 473.7 167.0 299.7 82.5 817.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 -86 -182 -159 -163 -70 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 -86 -182 -159 -163 -70 0 0   EBIT / employee   0 -96 -192 -169 -173 -70 0 0   Net earnings / employee   0 1,997 1,478 -1,346 228 822 0 0